Table 5.
Ref. | Design | Cases | Technical success | Clinical success | Complications1 |
Will et al[114] | RS | 12 | 100% (SPDD: 67%) | 50% | 43% |
Tessier et al[115] | RS | 36 | 92% (SPDD: 92%) | 69% | 55% |
Kahaleh et al[116] | RS | 13 | 100% (SPDD: 77%) | 77% | 15% |
Barkay et al[117] | RS | 21 | 86% (SPDD: 48%) | 86% | 10% |
Ergun et al[118] | RS | 20 | 100% (SPDD: 90%) | 72% | 20% |
Shah et al[96] | RS | 25 | 100% (SPDD: 86%) | 100% | 16% |
Vila et al[102] | RS | 19 | 58% (SPDD: NR) | NR | 26% |
Kurihara et al[119] | RS | 14 | 100% (SPDD: 93%) | 93% | 7% |
Fujii et al[120] | RS | 45 | 98% (SPDD: 73%) | 53% | 24% |
Total | 9 studies | 205 | 100% (58%-100%) | 74.5% (53%-100%) | 20%(7%-55%) |
Complications include: early and late, procedural and stent related. SPDD: Successful pancreatic duct drainage; RS: Retrospective study; NR: Not reported.